Details
Stereochemistry | ACHIRAL |
Molecular Formula | C16H15N3O2 |
Molecular Weight | 281.3092 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C1C=C(N=C2N1C=CC3=CC=CC=C23)N4CCOCC4
InChI
InChIKey=BVRDQVRQVGRNHG-UHFFFAOYSA-N
InChI=1S/C16H15N3O2/c20-15-11-14(18-7-9-21-10-8-18)17-16-13-4-2-1-3-12(13)5-6-19(15)16/h1-6,11H,7-10H2
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/17562705Curator's Comment: description was created based on several sources, including
https://www.google.com/patents/WO2003024949A1 | https://www.ncbi.nlm.nih.gov/pubmed/15658870
Sources: https://www.ncbi.nlm.nih.gov/pubmed/17562705
Curator's Comment: description was created based on several sources, including
https://www.google.com/patents/WO2003024949A1 | https://www.ncbi.nlm.nih.gov/pubmed/15658870
COMPOUND401 is the reversible and selective inhibitor of DNA-dependent protein kinase (DNA-PK) and mammalian target of rapamycin (mTOR) (IC50 values are 0.28 and 5.3 μM respectively). COMPOUND401 exhibits much reduced or no activity against 43 other commonly studied kinases, including PI 3-K, ATM, and ATR. Compound401 has been shown to induce apoptosis and inhibit FRAP-dependent growth in TSC1-/- murine embryo fibroblasts.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL3142 Sources: https://www.ncbi.nlm.nih.gov/pubmed/17562705 |
280.0 nM [IC50] | ||
Target ID: CHEMBL2842 Sources: https://www.ncbi.nlm.nih.gov/pubmed/17562705 |
5300.0 nM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/17562705
Rat-1 cells were cultured in serum-free medium for 20 h and then preincubated for 20 min with 0.1% vehicle (dimethyl sulfoxide) or COMPOUND401 (1, 5, 10 mkM). Cells were then stimulated for 10 min with 50 ng/ml PDGF or for 20 min with 10 mkM phenylephrine (PE). Cell lysate protein was analyzed on Western blots probed sequentially with antibodies to S6K1 (P-Thr389 and total), Akt (P-Ser473, P-Thr308, and total), or Erk (P-Thr202/Tyr204 and total).
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
168425-64-7
Created by
admin on Sat Dec 16 15:57:33 GMT 2023 , Edited by admin on Sat Dec 16 15:57:33 GMT 2023
|
PRIMARY | |||
|
10039361
Created by
admin on Sat Dec 16 15:57:33 GMT 2023 , Edited by admin on Sat Dec 16 15:57:33 GMT 2023
|
PRIMARY | |||
|
DTXSID20434626
Created by
admin on Sat Dec 16 15:57:33 GMT 2023 , Edited by admin on Sat Dec 16 15:57:33 GMT 2023
|
PRIMARY | |||
|
TN9PWB4UM5
Created by
admin on Sat Dec 16 15:57:33 GMT 2023 , Edited by admin on Sat Dec 16 15:57:33 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD